Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascular Targeted Photodynamic Therapy With WST11 for T1a Renal Tumours. PHASE IIa Histological Follow up Trial

NCT01573156 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01573156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01573156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascular Targeted Photodynamic Therapy With WST11 for T1a Renal Tumours. PHASE IIa Histological Follow up Trial
Lead sponsor
University of Oxford
Phase
Phase 1/2
Overall status
Terminated
Start date
May 31, 2013
Completion date
June 30, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cancer